Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2486081 | Journal of Pharmaceutical Sciences | 2010 | 13 Pages |
Abstract
The purpose of this study was to investigate the effect of thiolated polycarbophil as an adjuvant to enhance the permeation and improve the stability of a phosphorothioate antisense oligonucleotide (PTOâODN) on the nasal mucosa. Polycarbophilâcysteine (PCPâCys) was synthesized by the covalent attachment of Lâcysteine to the polymeric backbone. Cytotoxicity tests were examined on human nasal epithelial cells from surgery of nasal polyps confirmed by histological studies. Deoxyribonuclease I activity in respiratory region of the porcine nasal cavity was analyzed by an enzymatic assay. The enzymatic degradation of PTOâODNs on freshly excised porcine nasal mucosa was analyzed and protection of PCPâcysteine toward DNase I degradation was evaluated. Permeation studies were performed in Ussingâtype diffusion chambers. PCPâCys/GSH did not arise a remarkable mortal effect. Porcine respiratory mucosa was shown to possess nuclease activity corresponding to 0.69âKunitz units/mL. PTOâODNs were degraded by incubation with nasal mucosa. In the presence of 0.45% thiolated polycarbophil and 0.5% glutathione (GSH), this degradation process could be lowered. In the presence of thiolated polycarbophil and GSH the uptake of PTOâODNs from the nasal mucosa was 1.7âfold improved. According to these results thiolated polycarbophil/GSH might be a promising excipient for nasal administration of PTOâODNs. © 2009 WileyâLiss, Inc. and the American Pharmacists Association J Pharm Sci 99: 1427-1439, 2010
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
A. Vetter, R. Martien, A. BernkopâSchnürch,